Literature DB >> 10999909

Extracts from "clinical evidence": age related macular degeneration.

J J Arnold1, S H Sarks.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10999909      PMCID： PMC1127863          DOI： 10.1136/bmj.321.7263.741

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  34 in total

1.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; K L Linton
Journal:  Ophthalmology       Date:  1992-06       Impact factor: 12.079

2.  Controlled trial of laser photocoagulation of pigment epithelial detachments in the elderly: 4 year review.

Authors:  M J Barondes; S Pagliarini; I H Chisholm; A M Hamilton; A C Bird
Journal:  Br J Ophthalmol       Date:  1992-01       Impact factor: 4.638

Review 3.  An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

Authors:  A C Bird; N M Bressler; S B Bressler; I H Chisholm; G Coscas; M D Davis; P T de Jong; C C Klaver; B E Klein; R Klein
Journal:  Surv Ophthalmol       Date:  1995 Mar-Apr       Impact factor: 6.048

4.  Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-04

5.  Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1994-04

6.  Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1994-04

7.  Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1994-04

8.  The prevalence of age-related maculopathy in the Rotterdam Study.

Authors:  J R Vingerling; I Dielemans; A Hofman; D E Grobbee; M Hijmering; C F Kramer; P T de Jong
Journal:  Ophthalmology       Date:  1995-02       Impact factor: 12.079

9.  Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1994-09

10.  Visual results after surgical removal of subfoveal choroidal neovascular membranes.

Authors:  M A Thomas; J D Dickinson; N S Melberg; H E Ibanez; R S Dhaliwal
Journal:  Ophthalmology       Date:  1994-08       Impact factor: 12.079
View more
  9 in total

Review 1.  Age related macular degeneration.

Authors:  Amresh Chopdar; Usha Chakravarthy; Dinesh Verma
Journal:  BMJ       Date:  2003-03-01

Review 2.  Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review.

Authors:  C Meads; C Hyde
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

3.  Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement.

Authors:  R van Leeuwen; J R Vingerling; A Hofman; P T V M de Jong; B H Ch Stricker
Journal:  BMJ       Date:  2003-02-01

Review 4.  How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

Authors:  C G Owen; A E Fletcher; M Donoghue; A R Rudnicka
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

5.  Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.

Authors:  Andrew Lotery; Xiao Xu; Gergana Zlatava; Jane Loftus
Journal:  Br J Ophthalmol       Date:  2007-05-15       Impact factor: 4.638

6.  Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides.

Authors:  Javier Zarranz-Ventura; Patricia Fernández-Robredo; Sergio Recalde; Angel Salinas-Alamán; Francisco Borrás-Cuesta; Javier Dotor; Alfredo García-Layana
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 7.  Genetic basis of inherited macular dystrophies and implications for stem cell therapy.

Authors:  Carla B Mellough; David H W Steel; Majlinda Lako
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

8.  A randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology [ISRCTN78467674].

Authors:  Hannah Bartlett; Frank Eperjesi
Journal:  Nutr J       Date:  2003-10-10       Impact factor: 3.271

9.  Dietary analysis and patterns of nutritional supplement use in normal and age-related macular disease affected subjects: a prospective cross-sectional study.

Authors:  Hannah Bartlett; Frank Eperjesi
Journal:  Nutr J       Date:  2004-09-28       Impact factor: 3.271
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.